D3-GPC2-PBD

N/A

Report date: 2023/12/11 15:46:10

Base Information

Drug NameD3-GPC2-PBD
Drug Alias NameD3-GPC2-PBD
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionGlypican-2 inhibitors
TargetsGlypican-2
Therapy Area/IndicationsSmall Cell Lung CarcinomaNeuroblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChildrens Hospital of Philadelphia
China Registration ClassN/A

Develop Information

Active CompaniesChildrens Hospital of Philadelphia
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaNeuroblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A